Skip to main content
. 2020 Jul 28;23(4):286–296. doi: 10.1089/pop.2019.0128

Table 1.

Unadjusted Demographic Characteristics for Concurrent Use of Opioids and Other Central Nervous System-Active Medications: Opioids Only, Opioids Plus One, and Opioids Plus ≥Two

  All Mean or % Opioids only Mean or % Opioids plus 1 Mean or % Opioids plus ≥2 Mean or %
Number 209,947 119,744 58,463 31,740
Sex        
 Male 31.0 33.5 28.9 25.3
 Female 69.0 66.5 71.1 74.7
Age (years) 75.6 75.9 75.8 74.2
 65–69 25.7 24.6 24.9 31.6
 70–74 26.8 26.3 26.3 29.3
 75–79 19.6 19.8 19.9 18.2
 80–85 12.4 12.7 13.1 10.3
 ≥85 15.5 16.6 15.9 10.6
Minority (from zip codes)        
 Low 48.1 48.6 48.0 46.8
 Medium 46.9 46.3 47.3 48.7
 High 3.4 3.6 3.3 3.1
Median Income (from zip codes)        
 Low 18.0 17.2 18.9 19.1
 Medium 38.1 37.6 38.9 38.7
 High 43.6 44.8 41.9 42.0
Region        
 Midwest 17.5 18.1 17.4 15.7
 Northeast 16.3 17.3 15.6 13.9
 South 43.6 41.9 44.5 48.1
 West 22.3 22.4 22.3 22.1
Access to health care        
 PCP per 100,000 capita 131.0 131.7 130.6 129.3
Plan type        
 High 78.0 77.4 78.1 80.1
 Medium 2.9 2.9 3.1 2.7
 Other 19.1 19.7 18.9 17.2
HCC Score        
 ≤0.50 19.4 21.9 16.6 15.2
 0.50 to <1.20 40.1 41.9 38.6 36.0
 1.20 to <2.80 31.9 29.4 34.4 36.9
 ≥2.8 8.6 6.8 10.4 12.0
CCI Conditions        
 Dementia 10.2 8.8 11.0 14.2
 Chronic obstructive pulmonary disease 30.2 27.7 32.1 36.3
 Rheumatoid arthritis 8.8 8.0 9.6 10.6
PDG Conditions        
 Opioid use disorders 9.2 6.9 10.5 15.2
 Major depression 21.3 16.3 23.2 36.6
 Anxiety disorders 22.0 14.9 26.0 41.7
Insomnia dx 11.0 6.6 13.4 23.4
Pneumonia dx 10.3 8.9 11.2 13.7
Respiratory distress dx 28.9 27.1 30.2 33.3
Serotonin syndrome dx 0.5 0.4 0.6 1.0
Low back pain dx 46.4 41.5 51.0 56.3
Injury fall/hip fracture dx 11.8 11.6 11.3 13.4
 Hip fracture dx 2.4 2.5 2.3 2.3
 Injurious fall dx 10.8 10.6 10.4 12.4
Any inpatient hospitalization 32.3 33.2 29.8 33.4
Number of ER visits        
 0 53.5 54.0 54.8 49.1
 1–2 33.8 34.2 32.6 34.1
 ≥3 12.8 11.8 12.6 16.7
Opioid category        
 Long acting 9.6 5.4 12.6 20.1
 Short acting, other Schedule II 5.1 3.9 5.5 8.8
 Short acting, oxycodone 31.7 30.8 30.1 38.0
 Short acting, hydrocodone 49.2 48.8 48.7 51.6
 Short acting, Schedule III–IV 9.7 10.9 8.3 8.0
 Tramadol 46.5 49.9 44.6 37.1
Concurrent use of opioids with other CNS medications        
 Opioids and gabapentinoids 20.8 0.0 38.8 66.0
 Opioids and benzodiazepines 18.4 0.0 31.9 63.1
 Opioids and non-benzo hypnotics 12.3 0.0 17.5 49.3
 Opioids and muscle relaxants 7.8 0.0 8.7 35.7
 Opioids and antipsychotics 3.1 0.0 3.1 14.5

Notes: All variables are statistically significant at P < 0.0001. Missing categories deleted for brevity.

CCI, Charlson comorbidity index; CNS, central nervous system; dx, diagnoses codes; ER, emergency room; HCC, Hierarchical Condition Category; PCP, primary care provider; PDG, Psychiatric Diagnosis Groups.